Clinical trials: ROS1 Gene Translocation

Non-Small Cell Lung Cancer

Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

• Completed
• Age: 19 years and older
• Observational study
• Results posted

Prospective observational study to IDEntify patients with advanced/metastatic NSCLC and ALK and ROS1 translocation and to establish their therapeutic management (IDEALK\&ROS)

Trial name

NCT02679170

Testing

Crizotinib

Where

32 sites in Spain

Volunteers

692 people

Sponsor

Pfizer